MedTrace Logo

redoPOEM : Failure of a First POEM

NCT06044155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2024-07-10

No results posted yet for this study

Summary

observational study, measurement of efficacy in the cohort.

Conditions

  • Achalasia

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Arthur BERGER, MD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2024-02-28
Completion
2024-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044155 on ClinicalTrials.gov